Daisy Shu, PhD, a postdoctoral research fellow at Schepens Eye Research Institute of Mass Eye and Ear, was awarded the Association for Research in Vision and Ophthalmology (ARVO) 2021 Emerging...
Cris Jacoba, MD, the Chief Retina Fellow at Beetham Eye Institute at Joslin Diabetes Center, was one of four winners of the 2021 American Academy of Ophthalmology (AAO) EyeWiki® Resident and Fellows...
The destruction of retinal ganglion cells caused by the type II transmembrane protein Fas ligand (Fasl) is a key factor in glaucoma pathogenesis. Meredith Gregory-Ksander, PhD, Assistant Professor of...
Gena Heidary, MD, PhD, Assistant Professor of Ophthalmology and Director of Ophthalmology Fellowship Training at Boston Children's Hospital, has been selected to participate in the Association for...
Deborah K. VanderVeen, MD, Associate Professor of Ophthalmology at Harvard Medical School and a clinician scientist at Boston Children's Hospital, has been elected to the prestigious American...
Daisy Shu, PhD, a postdoctoral research fellow at Schepens Eye Research Institute of Mass Eye and Ear, was awarded the Association for Research in Vision and Ophthalmology (ARVO) 2021 Emerging...
Cris Jacoba, MD, the Chief Retina Fellow at Beetham Eye Institute at Joslin Diabetes Center, was one of four winners of the 2021 American Academy of Ophthalmology (AAO) EyeWiki® Resident and Fellows...
The destruction of retinal ganglion cells caused by the type II transmembrane protein Fas ligand (Fasl) is a key factor in glaucoma pathogenesis. 
Gena Heidary, MD, PhD
Deborah K. VanderVeen, MD